Rapid DNA testing for clinical diagnostics
Abacus Diagnostica’s proprietary, fully automated testing platform GenomEra® CDX takes DNA testing to a new level of convenience and simplicity.
Rapid molecular diagnostic tests critical to human health
Critical human pathogens and antibiotic resistance markers.
All-in-one PCR test chips with homogeneous detection in fully automated instrument.
Save time when it is critical.
Early detection of healthcare and perinatal infections
Timely administration of optimal antibiotic therapy.
Abacus Diagnostica’s mission is to provide innovative and simple-to-use solutions to enable routine use of DNA based testing without compromising the quality of results and move the molecular diagnostic to the next level of easiness.
Abacus Diagnostica launches worlds fastest molecular test for detection and differentiation of Norovirus genogroups I and II. GenomEra® Norovirus assay has received CE mark for IVD use and is now available for ordering. For more information please visit our Norovirus product page. For a special introductory offer please contact your local distributor.
We have begun the clinical evaluation studies for our new GenomEra Norovirus assay in three Finnish hospital laboratories. The assay is a direct RT-PCR test for stool samples with less than 2 minutes hands-on-time including only simple sample dilution and heating steps. The assay simultaneously detects and differentiates norovirus genogroups GI and GII with a turnaround time of around one hour. The assay will be available soon for diagnostic use (CE-IVD).
Human noroviruses, RNA viruses of the family Caliciviridae, are the most common cause of acute gastroenteritis worldwide and cause substantial levels of morbidity and mortality. Symptoms usually include acute onset of vomiting, abdominal cramps and diarrhoea. Noroviruses are also considered to be the most common viral agents of epidemic food-borne and water-borne viral gastroenteritis.
Interested for evaluation? Contact us or your local distributor.
GenomEra® MRSA/SA AC Test with the updated mecC detection has now received CE-IVD marking and is available. The test is compatible with both blood cultures and plate colony samples with excellent clinical performance. For more information please visit our MRSA/SA AC product page.